Scientists have uncovered a stealthy tactic used by the SARS-CoV-2 virus: one of its proteins can leap from infected cells to ...

A coiling protein “shell,” called a nucleocapsid, shown here, surrounds Ebola’s genetic material, which consists of single-strand RNA. University of Delaware researchers are simulating the way ...

A recent manuscript demonstrates that single point mutations in the specific region of the Nucleocapsid (N) protein, position 199-205, substantially increase the infectivity of the virus, ...

A recent paper by Syed et al. demonstrates that mutations in the Nucleocapsid (N) protein, one of the four structural proteins in SARS-CoV-2 in addition to the Spike protein, plays a critical role ...

The nucleocapsid protein is not currently targeted by any approved vaccine, and testing for anti-nucleocapsid antibodies tends to be used to test for past infection in vaccinated individuals.

Nucleocapsid levels differed from seronegative samples compared to seropositive samples for For nucleocapsid IgG, RBD IgG, RBD IgA, and RBD IgM. Specifically, seropositive samples were more likely ...

The researchers also hinted that the diminished anti-nucleocapsid antibody response among the vaccinated could lead to undercounting of breakthrough cases, when measured by antibody sampling.

The nucleocapsid’s cylindrical shape is made up of three layers; each layer plays a different role as the virus replicates in host cells. Before LJI’s imaging studies, ...

Scientists share detailed, complete images of a viral structure called the Ebola virus nucleocapsid. This breakthrough may accelerate the development of antivirals that target this viral structure ...

With anti-nucleocapsid IgG used as a marker for prior infection in 12,666 health care workers (Fig. S1B and Table S5), 226 of 11,543 (1.10 per 10,000 days at risk) ...